Deep learning assessment of metastatic relapse risk from digitized breast cancer histological slides
Ingrid Garberis(Institut Gustave Roussy), Magali Lacroix‐Triki(Université Paris-Saclay), M. Sapateiro(Université Paris-Saclay), Benoît Schmauch(Owl Research Institute), Sibille Everhard(Assistance Publique – Hôpitaux de Paris), Barbara Pistilli(Institut Gustave Roussy), V. Gaury, K. Elgui, J. Dachary, Aurélie Kamoun(FIND), Charlie Saillard(Laboratoire Procédés et Ingénierie en Mécanique et Matériaux), Pierre Courtiol, Lionel Guillou, J. Linhart, Meriem Sefta, V. Aubert, F. Brulport, Oussama Tchita, A. Jaeger, F. Bernigole(Université Paris-Saclay), Imad Bousaid(Institut Gustave Roussy), Loïc Herpin, Rémy Dubois, Jérôme Lemonnier(UniCancer Group), A. Sarrazin, Damien Drubay(Inserm), Suzette Delaloge(Institut Gustave Roussy), Mikael Azoulay(Institut Gustave Roussy), Alexandre Filiot, J-F Reboud, M. Auffret, Fabrice André(Inserm)
Cited by 10
Related Papers
3rd ESO–ESMO International Consensus Guidelines for Advanced Breast Cancer (ABC 3)
|Annals of Oncology|2016|2.1k
70-Gene Signature as an Aid to Treatment Decisions in Early-Stage Breast Cancer
|New England Journal of Medicine|2016|2k
AACR Project GENIE: Powering Precision Medicine through an International Consortium
|Cancer Discovery|2017|2k
Tailoring therapies—improving the management of early breast cancer: St Gallen International Expert Consensus on the Primary Therapy of Early Breast Cancer 2015
|Annals of Oncology|2015|1.8k
Palbociclib in Hormone-Receptor–Positive Advanced Breast Cancer
|New England Journal of Medicine|2015|1.6k